Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

Three women arrested when a woman fell seriously ill after using a weight loss jab, allegedly sourced from a North Yorkshire ...

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...

This article delves into the approved weight loss drugs in India, their costs, and the growing market for such medications.

A new study suggests that drugs like Ozempic and Mounjaro may reduce dementia risk. Researchers at the University of Galway found a 45% lower risk in ...

The researchers observed “significant” weight regain at eight, 12, and 20 weeks after discontinuation. They deduced that most patients gain back the weight they initially lost for an average of 20 ...

A little weight gain during the menopause is normal, but when it happens to a generation who came of age in the skinny-chic ...

India's weight-loss game is getting serious! The country's anti-obesity market is now worth ₹628 crore, and it's climbing ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...